TNXP R&D to Revenue
Tonix Pharmaceuticals Holding Corp · R&D to Revenue
TNXP R&D to Revenue
Latest reported143.36%period ending
TNXP Quarterly R&D/Revenue (0.00% → 143.36%)
Latest values, visible window
High-resolution chart · PNG
TNXP r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 143.3624% | |
| 264.8008% | |
| 314.3043% | |
| 282.3404% | |
| 541.5415% | |
| 306.1342% | |
| 321.34% | |
| 322.9624% | |
| 439.221% | |
| 518.2514% | |
| 453.0299% | |
| 527.7012% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -1,138,000% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |